| scholarly article | Q13442814 |
| P6179 | Dimensions Publication ID | 1064205894 |
| P356 | DOI | 10.1203/00006450-199601000-00021 |
| P698 | PubMed publication ID | 8825399 |
| P2093 | author name string | Verloove-Vanhorick SP | |
| Kok JH | |||
| Verkerk PH | |||
| Brand R | |||
| Den Ouden AL | |||
| P2860 | cites work | Low serum thyroxine concentrations and neural maturation in preterm infants | Q35603264 |
| Transient hypothyroxinaemia associated with developmental delay in very preterm infants | Q35628307 | ||
| Frequency of transient hypothyroxinaemia in low birthweight infants. Potential pitfall for neonatal screening programmes | Q38922723 | ||
| Normal ranges of T4 screening values in low birthweight infants | Q38934822 | ||
| Serum concentrations of thyrotropin, thyroid hormones and thyroid hormone-binding proteins during acute and recovery stages of idiopathic respiratory distress syndrome | Q39647690 | ||
| Low plasma triiodothyronine concentrations and outcome in preterm infants | Q41992608 | ||
| Follow-up at ages 5 and 7 years on mental development in children with hypothyroidism detected by Quebec Screening Program | Q43693376 | ||
| Impairments, disabilities, and handicaps of very preterm and very-low-birthweight infants at five years of age. The Collaborative Project on Preterm and Small for Gestational Age Infants (POPS) in The Netherlands | Q44780241 | ||
| Intellectual development at age 12 years of children with congenital hypothyroidism diagnosed by neonatal screening | Q44802347 | ||
| School performance in very preterm children | Q45213740 | ||
| Plasma thyroid hormones and prolactin in premature infants and their mothers after prenatal treatment with thyrotropin-releasing hormone | Q46167325 | ||
| Transient neonatal hypothyroxinemia and the auditory brainstem evoked response | Q48410154 | ||
| Standardised method of follow-up assessment of preterm infants at the age of 5 years: use of the WHO classification of impairments, disabilities and handicaps. Report from the collaborative Project on Preterm and Small for gestational age infants (P | Q50537679 | ||
| Multivariate analysis of psychomotor development in congenital hypothyroidism. | Q52065626 | ||
| P433 | issue | 1 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | birth mass | Q4128476 |
| preterm infant | Q45051448 | ||
| P304 | page(s) | 142-145 | |
| P577 | publication date | 1996-01-01 | |
| P1433 | published in | Pediatric Research | Q7159215 |
| P1476 | title | The relation between neonatal thyroxine levels and neurodevelopmental outcome at age 5 and 9 years in a national cohort of very preterm and/or very low birth weight infants | |
| P478 | volume | 39 |
| Q44664155 | A randomized, masked study of triiodothyronine plus thyroxine administration in preterm infants less than 28 weeks of gestational age: hormonal and clinical effects |
| Q48615984 | Absence of pestivirus antigen in brains with white matter damage |
| Q34590252 | Action of thyroid hormone in brain |
| Q35040305 | Cognitive and behavioral deficits in premature graduates of intensive care |
| Q52171731 | Congenital hypothyroidism: expanding the spectrum. |
| Q46359756 | Correlates of low thyroxine values at newborn screening among infants born before 32 weeks gestation |
| Q48219006 | Effect of primary congenital hypothyroidism upon expression of genes mediating murine brain glucose uptake |
| Q60676135 | Effect of thyroxine on brain microstructure in extremely premature babies: magnetic resonance imaging findings in the TIPIT study |
| Q61808045 | Emergent Prophylactic, Reparative and Restorative Brain Interventions for Infants Born Preterm With Cerebral Palsy |
| Q79820184 | Euthyroid women with autoimmune disease undergoing assisted reproduction technologies: the role of autoimmunity and thyroid function |
| Q44885330 | Evidence for developmental hypopituitarism in ill preterm infants |
| Q35615123 | Free thyroxine level in the high normal reference range prescribed for nonpregnant women may reduce the preterm delivery rate in multiparous |
| Q37664960 | Free thyroxine levels after very preterm birth and neurodevelopmental outcomes at age 7 years |
| Q36761575 | General background on the hypothalamic-pituitary-thyroid (HPT) axis |
| Q49434674 | Gestational age, not transient hyperthyrotropinemia impacts brain white matter diffusion tensor imaging in premature infants |
| Q43664481 | Growth-restricted premature infants are at increased risk for low thyroxine |
| Q64118035 | Hormonal Changes Associated With Intra-Uterine Growth Restriction: Impact on the Developing Brain and Future Neurodevelopment |
| Q33685942 | Hormone synthesis and storage in the thyroid of human preterm and term newborns: effect of thyroxine treatment |
| Q35687872 | Hypothyroxinaemia and thyroid function after preterm birth |
| Q48194232 | Hypothyroxinemia of prematurity and the risk of cerebral white matter damage |
| Q58050358 | Hypothyroxinemia: a subclinical condition affecting neurodevelopment |
| Q26850540 | Iodine and mental development of children 5 years old and under: a systematic review and meta-analysis |
| Q24244582 | Iodine supplementation for the prevention of morbidity and mortality in preterm infants |
| Q91894831 | Iodine supplementation for the prevention of mortality and adverse neurodevelopmental outcomes in preterm infants |
| Q24246337 | Iodine supplementation for the prevention of mortality and adverse neurodevelopmental outcomes in preterm infants |
| Q35286757 | Is some white matter damage in preterm neonates induced by a human pestivirus? |
| Q90076691 | Lack of association between hypothyroxinemia of prematurity and transient thyroid abnormalities with adverse long term neurodevelopmental outcome in very low birth weight infants |
| Q35869524 | Low iodine content in the diets of hospitalized preterm infants. |
| Q48169802 | Low maternal free thyroxine concentrations during early pregnancy are associated with impaired psychomotor development in infancy |
| Q59361836 | Motor nerve conduction velocity in very preterm infants in relation to l-thyroxine supplementation |
| Q46883678 | Neonatal iodine deficiency: clinical aspects |
| Q34976124 | Neonatal thyroid disorders |
| Q89763152 | Neurodevelopmental Outcomes at 42 Months After Thyroxine Supplementation in Infants Below 28 Weeks' Gestation: A Randomized Controlled Trial |
| Q34081573 | Phase 1 trial of 4 thyroid hormone regimens for transient hypothyroxinemia in neonates of <28 weeks' gestation |
| Q24244011 | Postnatal thyroid hormones for preterm infants with transient hypothyroxinaemia |
| Q24246422 | Postnatal thyroid hormones for preterm infants with transient hypothyroxinaemia |
| Q24243042 | Prophylactic postnatal thyroid hormones for prevention of morbidity and mortality in preterm infants |
| Q24244094 | Prophylactic postnatal thyroid hormones for prevention of morbidity and mortality in preterm infants |
| Q35289821 | Randomised trial of iodine intake and thyroid status in preterm infants |
| Q33690302 | Regulation of thyroid hormone metabolism during fetal development |
| Q40296232 | Relation of Thyroid Hormone Levels with Fluid-Resistant Shock among Preterm Septicemic Neonates |
| Q40798104 | Response to thyrotropin-releasing hormone stimulation tests in preterm infants with transient hypothyroxinemia of prematurity |
| Q37857349 | Review of primary hypothyroidism in very low birthweight infants in a perinatal centre in Hong Kong |
| Q24615594 | Role of late maternal thyroid hormones in cerebral cortex development: an experimental model for human prematurity |
| Q36585122 | TIPIT: A randomised controlled trial of thyroxine in preterm infants under 28 weeks' gestation |
| Q30493913 | TIPIT: a randomised controlled trial of thyroxine in preterm infants under 28 weeks gestation: magnetic resonance imaging and magnetic resonance angiography protocol |
| Q34098352 | The challenge of understanding cerebral white matter injury in the premature infant |
| Q61855759 | The complex aetiology of cerebral palsy |
| Q46851217 | The effect of L-thyroxine supplementation on retinal vascular development in neonatal rats |
| Q44006179 | The quantity of thyroid hormone in human milk is too low to influence plasma thyroid hormone levels in the very preterm infant |
| Q44422316 | Thyroid function in preterm infants 27-29 weeks of gestational age during the first four months of life: results from a prospective study comprising 80 preterm infants |
| Q33842325 | Thyroid hormone supplementation in preterm infants born before 28 weeks gestational age and neurodevelopmental outcome at age 36 months |
| Q33946222 | Thyroid testing during pregnancy at an academic Boston Area Medical Center. |
| Q51998239 | Thyroxine values from newborn screening of 919 infants born before 29 weeks' gestation. |
| Q48587464 | Tissue metabolism and plasma levels of thyroid hormones in critically ill very premature infants. |
| Q47118136 | Transient hypothyroidism in the newborn: to treat or not to treat |
| Q44171021 | Treatment of transient hypothyroxinemia of prematurity: a survey of neonatal practice |
| Q48220944 | White matter disorders of prematurity: association with intraventricular hemorrhage and ventriculomegaly. The Developmental Epidemiology Network |
Search more.